Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02716844
Other study ID # LUT11/16,B:30.2.HAC.0.20.05.04
Secondary ID
Status Completed
Phase N/A
First received March 3, 2016
Last updated March 23, 2016
Start date January 2015
Est. completion date March 2016

Study information

Verified date March 2016
Source Eastern Mediterranean University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Interventional

Clinical Trial Summary

Aim: Investigating the effects of Clinical Pilates Exercise on kinesiophobia, pain, functional status and quality of life of the patients diagnosed with osteoporosis.

Method: 47 patients were assessed and randomly divided into 2 groups. Exercise group patients joined exercise program regularly that was held 3 times a week, 1 hour a day, during 6 weeks with physiotherapist. Control group patients continued their normal daily lives without any exercise. After 7 patients quit the study for various reasons, 40 women with primary osteoporosis (control group n=20, exercise group n= 20), completed the study and were assessed at the beginning and at the end of 6 weeks. As assesment' measurements Tampa Kinesiophobia Scale (TKS), Visual Analog Scale (VAS), Short Form McGill (SF-McGill), Pain Disability Index (PDI), Oswestry Disability Index (ODI), Berg Balance Test (BBT), Timed Up- Go Test (TUG), Chair Sit-Stand Test (CSST), Chair Sit and Reach Test (CSRT), Back Scratch Test (BST), Quality of life Questionnaire European Foundation for Osteoporosis (QUALEFFO-41), Hospital Anxiety and Depression Scale (HADS), Satisfaction with Life Scale (SLS) and Health Assesment Questionnaire (HAQ) were performed.


Recruitment information / eligibility

Status Completed
Enrollment 47
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Female
Age group 50 Years to 75 Years
Eligibility Inclusion Criteria:

- Woman diagnosed with osteoporosis between the ages 50-75 within the last year

Exclusion Criteria

- History of fractures

- Joint replacements or fixation of the joints at the lower extremities or the spine

- Any neurological or muscle diseases

- Inability to continuously attend the exercise program

- Any secondary diseases resulting in decreased mobility or functional status

- Visual, hearing or mental problems that could prevent communication

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Exercise
Clinical Pilates exercise were given for 6 weeks, 3 days in a week

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Eastern Mediterranean University

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the level of fear and avoidance associated with movement assessed using the Tampa Kinesiophobia Scale at 6 weeks 40 osteoporosis patients filled Tampa Kinesiophobia Scale at the beginning and at the end of 6 weeks in order to measure the level of fear and avoidance associated with movement. If an individual receives a high score, according to the scale, this result indicates a high level of kinesiophobia . It has not a specific unit. There is not an adverse events in this test. At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of pain intensity in the morning assessed using Visual Analogue Scale (VAS) at 6 weeks. VAS is an horizontal line, 100 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current pain intensity. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks and recorded in centiemeters (cm). At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of pain intensity during activity assessed using Visual Analogue Scale (VAS) at 6 weeks. VAS is an horizontal line, 100 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current pain intensity. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks and recorded in centiemeters (cm). At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of pain intensity at rest assessed using Visual Analogue Scale (VAS) at 6 weeks. VAS is an horizontal line, 100 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current pain intensity. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks and recorded in centiemeters (cm). At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of experienced pain assessed with using Short Form - McGill Pain Questionnaire (SF-McGill) Short Form - McGill Pain Questionnaire (SF-McGill) provides a multidimensional evaluation of the experienced pain. Patients' pain descriptions (SF-McGill S), experienced pain level during study (Sf-McGill VAS) and total pain intensity measured via a 6-point Likert- Type Scale (SF-McGill L) was recorded. At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of influence of patients' general pain intensity on their daily life activities and functionality assessed using Pain Disability Index (PDI). Pain Disability Index (PDI) (score out of 70) is a questionnaire filled by the patients. At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of influence of patients' low back pain intensity on their daily life activities and functionality assessed using Oswestry Low Back Pain Disability Scale (ODI) Oswestry Low Back Pain Disability Scale (ODI)(score out of 70) is a questionnaire filled by the patients . At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of functional balance assessed using Berg Balance Test (BBT). Berg Balance Test (BBT)(score out of 56) evaluates postural control mechanism and dynamic and static balance while doing functional activities in adult population. This test was assessed by the physiotherapist. At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of functional balance assessed using The Timed Up and Go Test (TUG). The Timed Up and Go Test (TUG) assesses the functional balance and mobility of subjects. Patients stands up upon therapist's command walks 3 meters, turns around, walks back to the chair and sits down. The performance is repeated by the patience 3 times and the shortest performance time is recorded in seconds (sec). At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of lower extremity proximal muscle's strength and endurance assessed using Chair Sit and Stand Test (CSST) at 6 weeks. In Chair Sit and Stand Test (CSST), number of sitting-standing repetitions in 30 sec. was recorded by the physiotherapist. At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of functional flexibility of lower extremity assessed using Chair Sit and Stand Test (CSST) at 6 weeks. assesses the functional flexibility of the lower extremity in adult (23). Participant sits on the edge of a chair. One foot must remain flat on the floor. The other leg is extended forward with the knee straight, heel on the floor, and ankle bent at 90°. Patients place one hand on top of the other with tips of the middle fingers even. Patients keep the knee straight, and hold the reach for 2 seconds. If the fingertips touch the toes then the score is zero (0). If they do not touch, measure the distance between the fingers and the toes (a negative score/-), if they overlap, measure by how much (a positive score/+) and recorded in cm. At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of functional flexibility of upper extremity assessed using Back Scratch Test (BST) at 6 weeks. Back Scratch Test (BST)(cm) evaluates the functional flexibility of the patient's upper extremity. Patients are asked to rotate their shoulder externally with palms facing their back. Their hand fingers extend while trying to reach the lowest point, the other arm internally rotates while trying to reach the highest point. Patients are asked their fingertips to be closer to each other. If finger tips do not touch each other, the distance between them is recorded in cm assumed as a negative score, if the fingertips touch each other, then the score is assumed as zero. If they overlap, it is recorded in cm taking as positive score. Three repetitions are performed consecutively and the best score was recorded. At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of quality of life assessed using Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) at 6 weeks A. Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) examine the five dimensions of health such as pain, physical functioning, social activities, general health assessment and mental function of patients with osteoporosis. Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) was filled by the patients and score was calculated as percentage (%). At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of anxiety and depression assessed using Hospital Anxiety And Depression Scale (HADS) at 6 weeks This scale was filled by the patients. It has no special units. The elevation of the total score indicates the increased anxiety and depression levels (score out of 42). At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of chronic functional impairment assessed using Health Assessment Questionnaire (HAQ) at 6 weeks Health Assessment Questionnaire (HAQ) (score out of 24) is commonly used for evaluating the patients' chronic functional impairment caused by rheumatic diseases. This questionnaire was filled by the patients and it has no special units. At the beginning and at the end of 6 weeks Yes
Secondary Change in the level of life satisfaction assessed using Satisfaction with Life Scale (SLS) at 6 weeks This scale (score out of 35) was filled by the patients. It has no special units. At the beginning and at the end of 6 weeks Yes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Completed NCT03822078 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Phase 1
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Completed NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study
Recruiting NCT02635022 - Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Active, not recruiting NCT02617303 - Prevention of Falls and Its Consequences in Elderly People N/A
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Completed NCT03420716 - Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women N/A
Completed NCT02559648 - Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Phase 2
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Completed NCT02003716 - DeFRA Questionnaire as an Anamnestic Form N/A
Not yet recruiting NCT01854086 - Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday N/A
Unknown status NCT01913834 - Nasally and sc Administered Teriparatide in Healthy Volunteers Phase 1
Completed NCT01401556 - C-STOP Fracture Trial N/A
Completed NCT02143674 - Muscle Strengthening Exercises and Global Stretching in Elderly N/A
Completed NCT01757340 - Calorie Restriction With Leucine Supplementation N/A